INVESTMENT

Relmada Therapeutics director buys $64,750 in company stock

Moderator - Tomas KauerModerator - Tomas Kauer
Sep 12, 2024 - 00:00
Relmada Therapeutics director buys $64,750 in company stock
Read More

Tags:

Previous Article

Cyanotech executive Michael A. Davis buys shares worth $8,350

Next Article

Humacyte CEO sells over $2.3 million in company stock

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Moderator - Tomas Kauer
Moderator - Tomas Kauer

Related Posts

Moderna shares slip premarket as analysts cut ratings amid guidance worries

Moderna shares slip premarket as analysts cut ratings a...

Moderator - Tomas... Sep 13, 2024

M&S warns of possible price hikes as national insurance hike impacts costs

M&S warns of possible price hikes as national insurance...

Moderator - Tomas... Nov 9, 2024

Calling all solopreneurs: Create your business manifesto and win £10,000 with Adobe

Calling all solopreneurs: Create your business manifest...

Moderator - Tomas... Sep 19, 2024